Skip to content

Martin L Williams

9 papers in the library · 30 citations · publishing 1971-2026

Papers

Sort Most recent Most cited

PsiConnect: Multimodal Neuroimaging of Context-Dependent Brain and Behaviour Dynamics under Psilocybin.

Scientific Data May 21, 2026 Leonardo Novelli, Devon Stoliker, Tamrin Barta et al.

PsiConnect is a large-scale neuroimaging study designed to investigate context-dependent neural and subjective effects of psilocybin using multimodal neuroimaging. It combines functional, structural, and diffusion-weighted MRI with EEG to examine brain activity in 62 participants before and after a 19 mg dose of psilocybin. The design includes resting-state scans and three naturalistic...

Qualitative Research on Psilocybin-Assisted Psychotherapy for the Treatment of Mental Disorders: A Scoping Review

Psychedelic Medicine March 1, 2026 Jennifer Pincombe, Martin L Williams, Sean Carruthers et al.

Background: Psilocybin-assisted psychotherapy (PAP) may be an effective intervention for a range of mental disorders. However, there appears to be a relative lack of qualitative evidence to complement emerging quantitative findings. To our knowledge, no reviews have systematically mapped the literature on qualitative studies on PAP for the treatment of mental disorders with the intent to...

Eligibility for psychedelic therapy: Clinical trial medical exclusion criteria and their implications for hospital practice.

General Hospital Psychiatry 2026 Martin L Williams, Karen Hitchcock, Angus H Miller et al.

Clinical research in psychedelic-assisted therapies is flourishing following the resumption of human trials exploring classic psychedelics and their therapeutic application to a range of mental health conditions. Translation from research to the clinic is underway in Australia and appears imminent in several other countries. Classic psychedelics function primarily as agonists of a subgroup of...

Editorial: Beyond psilocybin: exploring the clinical potential of alternative and novel psychedelics.

Frontiers in Psychiatry April 23, 2025 Martin L Williams, Deborah Rudin, Yasmin Schmid et al.

However, psilocybin is but one of scores of compounds belonging to two main chemical classesphenethylamines and tryptamines -along with ergolines and an expanding array of other (mostly heterocyclic) alkaloids -that act as agonists of the serotonin 5-HT2A, 5-HT2C and 5-HT1A receptors responsible for the various phenomenological and putative therapeutic effects of classic psychedelics (8). In...

DOI: 10.3389/fpsyt.2025.1600812 (opens in new tab) Full text (opens in new tab) Psychedelic medicine Mental health treatments Alternative therapy Drug research +1

Rethinking Therapeutic Strategies for Anorexia Nervosa: Insights From Psychedelic Medicine and Animal Models.

FOCUS: The Journal of Lifelong Learning in Psychiatry July 1, 2024 Claire J. Foldi, Paul Liknaitzky, Martin L Williams et al.

Anorexia nervosa (AN) has the highest mortality rate of any psychiatric disease, yet available pharmacological treatments are largely ineffective due, in part, to an inadequate understanding of the neurobiological drivers that underpin the condition. The recent resurgence of research into the clinical applications of psychedelic medicine for a range of mental disorders has highlighted the...

DOI: 10.1176/appi.focus.24022012 (opens in new tab) Full text (opens in new tab) Psilocybin Neuroscience serotonin 5-ht2a Activity-based anorexia +7

Should Australian Psychology Consider Enhancing Psychotherapeutic Interventions with Psychedelic Drugs? A Call for Research

Australian psychologist December 1, 2018 Stephen Bright, Martin L Williams

International research is increasingly demonstrating that psychedelic‐assisted psychotherapy can enhance psychotherapeutic outcomes and be effective for some treatment‐refractory mental illnesses; however, there is an absence of any such research in Australia. A review of psychedelic science has been conducted with a focus on psychedelic‐assisted psychotherapy to highlight the degree to which...

Australia should be initiating a psychedelic research program: What are the barriers?

Australian & New Zealand Journal of Psychiatry September 28, 2016 N. Strauss, Stephen Bright, Martin L Williams 10 citations

Australian & New Zealand Journal of Psychiatry, 50(11) A recent review in Pharmacological Reviews highlights that over the last decade, a renaissance has occurred in psychedelic drug research in North America and Europe as investigators at Johns Hopkins School of Medicine, University of California, Los Angeles (UCLA), New York University and Imperial College London have embarked on studies that...

The NBOMe hallucinogenic drug series: Patterns of use, characteristics of users and self-reported effects in a large international sample.

Journal of Psychopharmacology August 1, 2014 Will Lawn, Monica J Barratt, Martin L Williams et al.

The NBOMe compounds are a novel series of hallucinogenic drugs that are potent agonists of the 5-HT2A receptor, have a short history of human consumption and are available to buy online, in most countries. In this study, we sought to investigate the patterns of use, characteristics of users and self-reported effects. A cross-sectional anonymous online survey exploring the patterns of drug use...

DOI: 10.1177/0269881114523866 (opens in new tab) Full text (opens in new tab) Demographics Nbome Hallucinogen Internet drug market +8

Characterization of Alkaloids in Palatable and Unpalatable Clones of Phalaris arundinacea L1

Crop Science March 1, 1971 Martin L Williams, R. F. Barnes, John M. Cassady 20 citations

We determined the types and amounts of alkaloids found in four reed canarygrass ( Phalaris arundinacea L.) genotypes that differed in palatability. The palatability differences had been demonstrated previously in cafeteria grazing trials with lambs. The following alkaloids were identified in reed canarygrass by combinations of gas‐liquid chromatography, thin‐layer chromatography, and mass...

DOI: 10.2135/cropsci1971.0011183x001100020014x (opens in new tab) Phalaris arundinacea Palatability Cafeteria Dry matter +4